SCHEMBL22609593

SCHEMBL22609593

CC(C)(C)OC(=O)N1CCCC[C@H]1COCc1ccc(Br)cc1

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
FPR3 P25089 1/20 0.47
FPR2 P25090 1/20 0.47
ABHD6 Q9BV23 1/20 0.43
DAGLA Q9Y4D2 1/20 0.43
KDM1A O60341 1/20 0.42
CACNA1B Q00975 1/20 0.42
PRMT5 O14744 1/20 0.41
KMT2A Q03164 1/20 0.41
PDE8B O95263 1/20 0.40
ATM Q13315 2/20 0.40
ALOX5AP P20292 3/20 0.40
PARP1 P09874 1/20 0.40
FEN1 P39748 1/20 0.40
KLK7 P49862 1/20 0.39
UCHL1 P09936 1/20 0.39
CHRNB2 P17787 1/20 0.39
CHRNA7 P36544 1/20 0.39
CHRNA4 P43681 1/20 0.39
OPRK1 P41145 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21071021 1.00 FPR3 (0.47) FPR3FPR2ABHD6DAGLAKDM1A
SCHEMBL6610814 0.89 DAGLA (0.54) ABHD6DAGLAKDM1APRMT5KMT2A
SCHEMBL20129716 0.89 DAGLA (0.54) ABHD6DAGLAKDM1APRMT5KMT2A
SCHEMBL21070281 0.87 ABHD6 (0.42) ABHD6DAGLAKDM1APRMT5KMT2A
SCHEMBL12260685 0.85 KLK7 (0.42) FPR3FPR2ABHD6DAGLAKDM1A
SCHEMBL4664791 0.85 KLK7 (0.52) ABHD6DAGLAKDM1APRMT5KMT2A
SCHEMBL7908485 0.85 KLK7 (0.52) ABHD6DAGLAKDM1APRMT5KMT2A
SCHEMBL7908488 0.85 KLK7 (0.52) ABHD6DAGLAKDM1APRMT5KMT2A
SCHEMBL30428955 0.85 DAGLA (0.48) ABHD6DAGLAKDM1APRMT5KMT2A
SCHEMBL12663132 0.83 ALOX5AP (0.41) FPR3FPR2ABHD6DAGLAKDM1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3731869-A1 IRAK DEGRADERS AND USES THEREOF Kymera Therapeutics, Inc. (US) 2020-11-04 EP disclosed